Indegene is a digital-first life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed, precision, and efficiency. As a specialized company, it combines healthcare domain expertise, fit-for-purpose technology, and an agile operating model to solve the most complex problems in the healthcare industry. The company’s integrated portfolio spans commercial, medical, regulatory, and R&D / Clinical operations of life sciences companies. 

The company enjoys a differentiated positioning as a digital-first commercialization and transformation partner to the life sciences industry. This stems from a combination of strong attributes cultivated over the years - deep domain expertise, a technology-first mindset, trusted customer relationships, and an agile operating model. As the industry evolves, the company continues to bolster its strengths, infusing AI into its solutions and driving operational excellence to create sustained value for stakeholders.

Solutions and Business Models

• Enterprise Commercial Solutions: It caters to the digital marketing operations of the life sciences companies, a significant cost item.
• Omnichannel Activation: It augments the promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels.
• Enterprise Medical Solutions: It aims to consolidate large-scale regulatory and medical operations for life sciences companies through its Centers of Excellence (CoEs), comprising multi-disciplinary teams that work on one or more client engagements.
• Others: It also offers Enterprise Clinical Solutions and Consultancy Services. 

Business area of the company

The company offers solutions straddling the different stages of the commercialization lifecycle of drugs and medical devices. It caters to the commercial function needs of life sciences companies through its Enterprise Commercial Solutions and its Omnichannel Activation Solutions. For the medical and R&D function needs, it operates through its Enterprise Medical Solutions and Enterprise Clinical Solutions.

Key Awards, accreditations and recognition

• 2016: Ranked 88th among ‘India’s Best Companies to Work for’ by Great Place to Work, India and the Economic Times.
• 2016: Received the Business World HR Excellence Award for ‘Best Implementation of HR Technology’.
• 2017: Ranked 86th among ‘India’s Best Companies to Work for’ by Great Place to Work, India and the Economic Times.
• 2017: Recognised as one of the ‘100 Best Companies for Women in India’ by Working Mother Media and Avtar Group.
• 2017: Recognised as one of the ‘Healthy Workplaces in India’ by Arogya World.
• 2018: Ranked 60th among ‘India’s Best Companies to Work for’ by Great Place to Work, India and the Economic Times.
• 2018: Recognised as one of the ‘100 Best Companies for Women in India’ by Working Mother Media and Avtar Group.
• 2019: Recognised as one of the ‘100 Best Companies for Women in India’ by Working Mother Media and Avtar Group.
• 2019: Recognised as one of the ‘Platinum Healthy Workplaces in India’ by Arogya World India Trust.
• 2020: Ranked in the ‘Top 50’ category of ‘India’s Best Workplaces for Women’ by Great Place to Work, India.
• 2020: Ranked 96th among ‘India’s Best Companies to Work for’ by Great Place to Work, India.
• 2020: Recognised as one of the ‘100 Best Companies for Women in India’ by Working Mother Media and Avtar Group.
• 2020: Recognised as one of ‘India’s Best Workplaces in Health and Wellness’ by Great Place to Work, India.
• 2021: Ranked 100th among ‘India’s Best Companies to Work for’ by Great Place to Work, India and the Economic Times.
• 2021: Ranked in the ‘Top 100’ category of ‘India’s Best Workplaces for Women’ (large organisations) by Great Place to Work, India.
• 2021: Recognised as one of the ‘100 Best Companies for Women in India’ by Seramount (formerly Working Mother Media) and Avtar Group.
• 2021: Recognised as one of ‘India’s Best Workplaces in Health and Wellness’ by Great Place to Work, India.
• 2022: Ranked 438th among ‘Asia-Pacific High-Growth Companies’ by Financial Times.
• 2022: Recognised as a leader by Everest Group, in its ‘Life Sciences Commercial Services Specialists PEAK Matrix Assessment 2022’. 
• 2022: Recognised for its ‘Commitment to being a Great Place to Work’ by Great Place to Work, India.
• 2022: Recognised as ‘India’s Best Workplaces in Health and Wellness’ by Great Place to Work, India.
• 2023: Recognised as one of ‘India’s Best Workplaces in Professional Services’ by Great Place to Work, India.
• 2023: Awarded under the ‘Data Engineering for Good’ category at the Data Engineering Awards, 2023 by Analytics India Magazine.
• 2023: Awarded the ‘Best Overall AI-based Analytics Solution’ at the AI Breakthrough Awards, 2023.
• 2023: Recognised as a life sciences specialist with deep domain pockets and outcomes to match by HFS Horizons in the Life Sciences Service Providers, 2023.
• 2023: Awarded the Platinum level by Arogya World at the Healthy Workplace Conference and Awards, 2023.
• 2023: Certified as a great workplace by Great Place to Work Institute, India.
• 2024: Recognised as a leader by Everest Group, in its ‘Life Sciences Digital Services Specialists PEAK Matrix Assessment 2024’.
• 2024: Certified as a great workplace by Great Place to Work Institute, India. 

Major events and milestones

• 1998: Indegene founded.
• 2000: Introduced medical education services to Indian pharmaceutical companies Launched Indegene Mobile Health System (IMHS) for medical doctors to easily access licensed medical content via PalmPilots.
• 2001: Recognized by Lancet as the most credible source of specialized medical information in India.
• 2001: Selected by WHO as their partner to implement a nationwide healthcare information project.
• 2003: Made a successful entry into sales training through launch of e-learning platform in diabetes across S.E. Asia.
• 2004: Incorporated 100% subsidiaries in the United States and Singapore.
• 2005: Nadathur Investments invested in Indegene.
• 2005: Set up operations in the United States.
• 2005: Acquired Medsn, a pharma sales training company in the United States.
• 2006: Ramped up operations in Southeast Asia.
• 2006: Acquired MedCases, a medical e-learning solutions company in the United States.
• 2007: Kicked off operations in Europe.
• 2007: Received ISO 9001 and ISO 27001 certifications.
• 2007: Launched Medical Affairs services.
• 2010: Built China Operation Center at Shanghai and Dalian.
• 2011: Launched Analytics services.
• 2012: Introduced Regulatory Affairs and Safety services.
• 2012: Acquired Aptilon, a customer engagement technology company.
• 2013: Acquired Total Therapeutic Management (TTM), a healthcare quality improvement and clinician engagement company.
• 2015: Acquired SmartCare, a population health analytics platform.
• 2016: Acquired Skura Technologies to expand omnichannel and commercial solutions.
• 2016: Acquired Encima to strengthen omnichannel analytics capabilities.
• 2016: Introduced next-generation, fully integrated product commercialization solutions.
• 2016: Acquired Wincere to strengthen footprint in R&D and Medical offerings for life sciences.
• 2017: Introduced Clinical services.
• 2019: Acquired DT Associates, a digital transformation and customer experience consulting firm in the UK.
• 2019: Launched Indegene Digital Summit, a flagship thought leadership event.
• 2020: Set up operations in Japan.
• 2021: The Carlyle Group and Brighton Park Capital invested $200 million in Indegene.
• 2021: Indegene refreshed its brand to align with its purpose - To enable healthcare organizations be future-ready.
• 2021: Strengthened pricing, reimbursement and market access capabilities with MME acquisition.
• 2022: Acquired CultHealth, a full-service healthcare marketing agency to elevate brand experience.
• 2023: Opened strategic center in Germany.
• 2024: Set up a new global delivery center in Hyderabad.
• 2024: Acquired Trilogy Writing & Consulting GmbH, a medical writing consultancy.
• 2024: Indegene listed on NSE and BSE.
• 2025: Acquired MJL Life Sciences to expand healthcare communications in the UK.
• 2025: Launched a new entity in Spain.
• 2025: Opened a new center in London.